This combination has shown promise in improving glycemic control while minimizing the risk of hypoglycemia and weight gain, common adverse effects associated with insulin therapy.2 Recent studies have demonstrated the efficacy and safety of IDegLira in various populations, highlighting its potential as an effective treatment option for T2D.3 Here, INS is linked to Hypoglycemia.